Notice of Improvements. In the event Licensee (on behalf of itself or its Affiliates) develops any Additional P&G Improvements, Licensee shall promptly provide Licensor with written notice thereof.
Notice of Improvements. The City must give Company reasonable notice of plans for improvements to Public Grounds or Public Ways where the City has reason to believe that Electric Facilities may affect or be affected by the improvement. The notice must contain: (i) the nature and character of the improvements, (ii) the Public Grounds and Public Ways upon which the improvements are to be made, (iii) the extent of the improvements, (iv) the time when the City will start the work, and (v) if more than one Public Ground or Public Way is involved, the order in which the work is to proceed. The notice must be given to Company a sufficient length of time in advance of the actual commencement of the work to permit Company to make any necessary additions, alterations or repairs to its Electric Facilities.
Notice of Improvements. If Licensor files a patent application anywhere in the Territory within the twelve (12) months following the Effective Date for any Improvement as defined herein in the Field of Use (“Improvement Patent Application”), Licensor shall provide written notice to Licensee within thirty (30) days after the filing date of the patent application, with a copy of the patent application for Licensee to evaluate the Improvement.
Notice of Improvements. In the event that Sano develops or acquires the rights to (including the right to license or sub-license) any Improvements during the term of this Agreement, Sano shall promptly disclose such full and complete information relating to such Improvements to BMS.
Notice of Improvements. Verenium and BP will each notify the other parties in writing of any Improvements to the Verenium Background Technology and the BP Background Technology as they arise during the JDP Term that are subject to licenses set forth in Sections 3.1 and 3.2.
Notice of Improvements. If a Party files a patent application anywhere in the Territory for any Improvement, such Party shall provide written notice to the other Party within sixty (60) days after the filing date of the patent application, with a copy of the patent application and such other details of the Improvement as the other Party reasonably requires to effectively evaluate the Improvement.
Notice of Improvements. 7.1.1 Promptly after the development by or on behalf of Licensor or, where applicable, any assignment or transfer to Licensor, of any Improvement, Licensor shall provide written notice to Licensee (“Improvement Notice”). The Improvement Notice shall include a description of the Improvement and a summary of the subject matter claimed in any Improvement patents.
7.1.2 If Licensee wishes to include any Improvement as a Licensed Product under this Agreement, Licensee shall provide within ninety (90) days of the Improvement Notice written notice to Licensor specifying that the Licensee wishes to include the Improvement as a Licensed Product. Immediately upon Licensee's notice to Licensor, each Improvement identified by Licensee in its notice hereunder will be a Licensed Product under this Agreement. No rights are granted to Licensee hereunder to make any Improvement, and Licensee shall not undertake to make any Improvement or obtain any Improvement other than from Licensor or its designee.
7.1.3 In the event during the Term of this Agreement, Licensor receives inquiries from any Third Party for an exclusive license to market, sell and distribute a Licensed Product in any of jurisdictions of [***], [***], or [***] for any of the Licensee Indications, Licensor shall in 100004170 good faith provide [***]. [***], the Parties will proceed with the license and supply arrangement for the Licensed Product for any of jurisdictions of [***], [***], or [***] then Licensor shall give due consideration to Licensee’s co-ownership of any intellectual property developed in the Clinical Trial and provide an equivalent economic benefit in respect of the business arrangements between the Licensor and the Licensee in such jurisdictions. [***].
7.1.4 In the event during the Term of this Agreement, Licensor receives inquiries for an exclusive license to market, sell and distribute a Licensed Product in [***] for any of the Licensee Indications, Licensor shall in good faith provide Licensee with an opportunity to discuss and negotiate with Licensor for the same to arrive at mutually acceptable commercial terms. In the event that the Parties agree to proceed with the license and supply arrangement for the Licensed Product [***] then Licensor shall give due consideration to Licensee’s co-ownership of any intellectual property developed in the Clinical Trial and provide an equivalent economic benefit in respect of the business arrangements between the Licensor and the Licensee in such j...
Notice of Improvements. All Improvements and all new developments relating to the Products to which the Licensor or Licensee shall become entitled, or which shall be devised by the Licensor or Licensee, shall without delay be disclosed in confidence to the other parties.
Notice of Improvements. During the Term, Licensor shall on at least a semiannual basis provide Licensee with written notice of all Improvements in the LMC Field or the LMT Field (as the case may be) conceived, discovered or developed by Licensor or any of its Affiliates since the Effective Date or last providing such notice to Licensee (an “Improvement Notice”). The Improvement Notices shall include a written description of each such Improvement in sufficient detail so as to allow its technical and proprietary merit to be promptly and fully evaluated. Such Improvements shall automatically be licensed to the Licensee pursuant to this Article 2.
Notice of Improvements. If GTX files a patent application for any Improvement within two (2) years following the Effective Date, GTX shall provide written notice to Inpixon within twenty (20) Business Days after the filing date of the patent application, with a copy of relevant GTX Confidential Information, including the patent application and such other details of the Improvement as Inpixon reasonably requires to effectively evaluate the Improvement.
